Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,364 | N/A | -5,039 | -5,031 | -5,026 |
| Depreciation Amortization | 58 | N/A | 188 | 179 | 150 |
| Accounts receivable | 127 | N/A | -40 | 85 | 72 |
| Other Working Capital | 722 | N/A | 13 | 198 | -24 |
| Other Operating Activity | 471 | 0 | 262 | -131 | 323 |
| Operating Cash Flow | $-4,986 | $N/A | $-4,616 | $-4,700 | $-4,506 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | N/A | -4,084 | 1,994 | 1,026 |
| PPE Investments | 49 | N/A | -383 | -303 | -402 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -67 |
| Purchase Sale Intangibles | -30 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -30 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $19 | $N/A | $-4,466 | $1,692 | $557 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,596 | N/A | 9,171 | N/A | 7,646 |
| Common Stock Repurchased | -476 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -57 | 0 | -399 | 0 | -333 |
| Financing Cash Flow | $7,093 | $N/A | $8,772 | $N/A | $7,313 |
| Exchange Rate Effect | 58 | N/A | -36 | 162 | 97 |
| Beginning Cash Position | 5,031 | N/A | 4,571 | 7,417 | 3,956 |
| End Cash Position | 7,214 | N/A | 4,226 | 4,571 | 7,417 |
| Net Cash Flow | $2,183 | $N/A | $-345 | $-2,846 | $3,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,986 | N/A | -4,616 | -4,700 | -4,506 |
| Capital Expenditure | -5 | N/A | -383 | -303 | -402 |
| Free Cash Flow | -4,991 | 0 | -4,998 | -5,002 | -4,908 |